These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23134514)

  • 1. Factors that influence radioactive iodine use for thyroid cancer.
    Papaleontiou M; Banerjee M; Yang D; Sisson JC; Koenig RJ; Haymart MR
    Thyroid; 2013 Feb; 23(2):219-24. PubMed ID: 23134514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgeon training and use of radioactive iodine in stage I thyroid cancer patients.
    Schuessler KM; Banerjee M; Yang D; Stewart AK; Doherty GM; Haymart MR
    Ann Surg Oncol; 2013 Mar; 20(3):733-8. PubMed ID: 23224826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer.
    Wallner LP; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Lubitz C; Hawley ST; Haymart MR
    J Clin Endocrinol Metab; 2021 May; 106(6):e2402-e2412. PubMed ID: 33687063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer.
    Haymart MR; Banerjee M; Yang D; Stewart AK; Koenig RJ; Griggs JJ
    Cancer; 2013 Jan; 119(2):259-65. PubMed ID: 22744940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between extent of thyroid cancer surgery and use of radioactive iodine.
    Haymart MR; Banerjee M; Yang D; Stewart AK; Doherty GM; Koenig RJ; Griggs JJ
    Ann Surg; 2013 Aug; 258(2):354-8. PubMed ID: 23567930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basis for physician recommendations for adjuvant radioiodine therapy in early-stage thyroid carcinoma: principal findings of the Canadian-American thyroid cancer survey.
    Sawka AM; Goldstein DP; Thabane L; Brierley JD; Tsang RW; Rotstein L; Kamalanathan S; Zhao B; Gafni A; Straus S; Ezzat S
    Endocr Pract; 2008 Mar; 14(2):175-84. PubMed ID: 18308655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of evidence-based guidelines reduces radioactive iodine treatment in patients with low-risk differentiated thyroid cancer.
    Sacks W; Wong RM; Bresee C; Braunstein GD
    Thyroid; 2015 Apr; 25(4):377-85. PubMed ID: 25578116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease severity and radioactive iodine use for thyroid cancer.
    Haymart MR; Muenz DG; Stewart AK; Griggs JJ; Banerjee M
    J Clin Endocrinol Metab; 2013 Feb; 98(2):678-86. PubMed ID: 23322816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physicians' preferencesfor radioiodine treatment of differentiated thyroid cancer in Brazil: an observational study.
    Padovani RDP; Pansani IF; Marone MMS; Vaisman F; Maia ALS; Dora JMS; Ramos HE; Hoff AAFO; Coura GB
    Arch Endocrinol Metab; 2024; 68():e230228. PubMed ID: 39420903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Perceived Lack of Choice in Receipt of Radioactive Iodine for Treatment of Differentiated Thyroid Cancer.
    Wallner LP; Reyes-Gastelum D; Hamilton AS; Ward KC; Hawley ST; Haymart MR
    J Clin Oncol; 2019 Aug; 37(24):2152-2161. PubMed ID: 31283406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Population-Level and Institutional-Level Prescribing Habits of Radioiodine Therapy for Papillary Thyroid Cancer.
    Jacobs D; Breen CT; Pucar D; Holt EH; Judson BL; Mehra S
    Thyroid; 2021 Feb; 31(2):272-279. PubMed ID: 32811347
    [No Abstract]   [Full Text] [Related]  

  • 12. Associating radioiodine therapy in hyperthyroidism with cancer mortality: robust or random results of a statistical analysis?
    Iakovou I; Giannoula E; Chatzipavlidou V; Sachpekidis C
    Hell J Nucl Med; 2020; 23(1):94-95. PubMed ID: 32361719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of radioactive iodine for thyroid cancer.
    Haymart MR; Banerjee M; Stewart AK; Koenig RJ; Birkmeyer JD; Griggs JJ
    JAMA; 2011 Aug; 306(7):721-8. PubMed ID: 21846853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Too Much of a Good Thing: Radioactive Iodine Ablation Use for Micropapillary Thyroid Carcinoma.
    Chae AW; Martinez SR
    Am Surg; 2018 May; 84(5):637-643. PubMed ID: 29966562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice patterns among thyroid cancer surgeons: implications of performing a prophylactic central neck dissection.
    Deutschmann MW; Chin-Lenn L; Nakoneshny SC; Dort JC; Pasieka JL; Chandarana SP
    J Otolaryngol Head Neck Surg; 2016 Oct; 45(1):55. PubMed ID: 27793192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
    Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
    Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma.
    Kim M; Kim BH; Kim JM; Kim EH; Kim K; Pak K; Jeon YK; Kim SS; Park H; Kang T; Lee BJ; Kim IJ
    Cancer; 2019 Aug; 125(16):2803-2809. PubMed ID: 31216369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioactive iodine in differentiated thyroid cancer: a national database perspective.
    Orosco RK; Hussain T; Noel JE; Chang DC; Dosiou C; Mittra E; Divi V; Orloff LA
    Endocr Relat Cancer; 2019 Oct; 26(10):795-802. PubMed ID: 31443087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of radioactive iodine for treatment of low-risk thyroid cancer: a systematic analysis of the peer-reviewed literature from 1966 to April 2008.
    Sacks W; Fung CH; Chang JT; Waxman A; Braunstein GD
    Thyroid; 2010 Nov; 20(11):1235-45. PubMed ID: 21062195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The overuse of radioactive iodine in low-risk papillary thyroid cancer patients.
    Moten AS; Zhao H; Willis AI
    Surg Oncol; 2019 Jun; 29():184-189. PubMed ID: 31196486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.